AbbVie Stumbles as Humira's Fortress Is Breached by Rivals

(Bloomberg) -- AbbVie Inc. has long said that its blockbuster drug Humira is protected by a fortress of patents. But on Friday, investors got a first look at what could happen when those walls are ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.